Myrbetriq™ (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement
Status:
Completed
Trial end date:
2019-01-30
Target enrollment:
Participant gender:
Summary
The objective of this pilot study is to assess whether Myrbetriq™ will improve post-operative
ureteral pain and discomfort, reduce bladder storage symptoms and increase quality of life
following ureteral stenting.
Phase:
Phase 2
Details
Lead Sponsor:
Southern Illinois University
Collaborators:
Astellas Scientific & Medical Affairs, Inc. Sisters of the Third Order of St. Francis